Veterinary Medicines

Rymasol-50, 50 mg/ml süstelahus veistele, hobustele ja ponidele

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Rymasol-50, 50 mg/ml süstelahus veistele, hobustele ja ponidele
Active substance:
  • Carprofen
Target species:
  • Cattle
  • Horse
  • Horse (pony)
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        4
        day
      • Milk
        no withdrawal period
    • Horse (pony)
      • Meat and offal
        4
        day
      • Milk
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2272
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 5/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."